Shanghai Pioneer Holding Ltd

Informe acción SEHK:1345

Capitalización de mercado: HK$2.4b

Shanghai Pioneer Holding Resultados de beneficios anteriores

Pasado controles de criterios 2/6

Shanghai Pioneer Holding ha aumentado sus beneficios a una tasa media anual de 23.4%, mientras que los beneficios de la industria de Healthcare han experimentado un crecimiento de 11.2% anual. Los ingresos han ido creciendo a una tasa media de 5.3% al año. La rentabilidad financiera de Shanghai Pioneer Holding es de 12.8%, y sus márgenes netos son de 9.9%.

Información clave

23.4%

Tasa de crecimiento de los beneficios

24.1%

Tasa de crecimiento del BPA

Crecimiento de la industria Healthcare 11.3%
Tasa de crecimiento de los ingresos5.3%
Rentabilidad financiera12.8%
Margen neto9.9%
Última actualización de beneficios30 Jun 2024

Actualizaciones de resultados anteriores recientes

Shanghai Pioneer Holding's (HKG:1345) Shareholders Have More To Worry About Than Only Soft Earnings

Apr 01
Shanghai Pioneer Holding's (HKG:1345) Shareholders Have More To Worry About Than Only Soft Earnings

Recent updates

Shareholders Should Be Pleased With Shanghai Pioneer Holding Ltd's (HKG:1345) Price

Jul 15
Shareholders Should Be Pleased With Shanghai Pioneer Holding Ltd's (HKG:1345) Price

Shanghai Pioneer Holding's (HKG:1345) Dividend Will Be CN¥0.024

Apr 24
Shanghai Pioneer Holding's (HKG:1345) Dividend Will Be CN¥0.024

Shanghai Pioneer Holding (HKG:1345) Will Pay A Dividend Of CN¥0.024

Apr 03
Shanghai Pioneer Holding (HKG:1345) Will Pay A Dividend Of CN¥0.024

Shanghai Pioneer Holding's (HKG:1345) Shareholders Have More To Worry About Than Only Soft Earnings

Apr 01
Shanghai Pioneer Holding's (HKG:1345) Shareholders Have More To Worry About Than Only Soft Earnings

Shanghai Pioneer Holding Ltd (HKG:1345) Could Be Riskier Than It Looks

Mar 22
Shanghai Pioneer Holding Ltd (HKG:1345) Could Be Riskier Than It Looks

Shanghai Pioneer Holding (HKG:1345) Is Finding It Tricky To Allocate Its Capital

Feb 26
Shanghai Pioneer Holding (HKG:1345) Is Finding It Tricky To Allocate Its Capital

Does Shanghai Pioneer Holding (HKG:1345) Have A Healthy Balance Sheet?

Oct 21
Does Shanghai Pioneer Holding (HKG:1345) Have A Healthy Balance Sheet?

Shanghai Pioneer Holding (HKG:1345) Has Announced That It Will Be Increasing Its Dividend To CN¥0.024

Sep 18
Shanghai Pioneer Holding (HKG:1345) Has Announced That It Will Be Increasing Its Dividend To CN¥0.024

Shanghai Pioneer Holding (HKG:1345) Is Increasing Its Dividend To CN¥0.024

Sep 01
Shanghai Pioneer Holding (HKG:1345) Is Increasing Its Dividend To CN¥0.024

Here's Why We Think Shanghai Pioneer Holding (HKG:1345) Is Well Worth Watching

Aug 09
Here's Why We Think Shanghai Pioneer Holding (HKG:1345) Is Well Worth Watching

Shanghai Pioneer Holding's (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year

Apr 14
Shanghai Pioneer Holding's (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year

Shanghai Pioneer Holding's (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year

Mar 31
Shanghai Pioneer Holding's (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year

Shanghai Pioneer Holding (HKG:1345) Seems To Use Debt Rather Sparingly

Dec 15
Shanghai Pioneer Holding (HKG:1345) Seems To Use Debt Rather Sparingly

China Pioneer Pharma Holdings' (HKG:1345) Dividend Will Be Reduced To CN¥0.018

Sep 21
China Pioneer Pharma Holdings' (HKG:1345) Dividend Will Be Reduced To CN¥0.018

China Pioneer Pharma Holdings' (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year

Sep 02
China Pioneer Pharma Holdings' (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year

China Pioneer Pharma Holdings (HKG:1345) Has More To Do To Multiply In Value Going Forward

Jun 22
China Pioneer Pharma Holdings (HKG:1345) Has More To Do To Multiply In Value Going Forward

China Pioneer Pharma Holdings (HKG:1345) Has Announced That Its Dividend Will Be Reduced To HK$0.064

Apr 14
China Pioneer Pharma Holdings (HKG:1345) Has Announced That Its Dividend Will Be Reduced To HK$0.064

China Pioneer Pharma Holdings (HKG:1345) Will Be Hoping To Turn Its Returns On Capital Around

Jan 16
China Pioneer Pharma Holdings (HKG:1345) Will Be Hoping To Turn Its Returns On Capital Around

These 4 Measures Indicate That China Pioneer Pharma Holdings (HKG:1345) Is Using Debt Safely

Oct 11
These 4 Measures Indicate That China Pioneer Pharma Holdings (HKG:1345) Is Using Debt Safely

China Pioneer Pharma Holdings (HKG:1345) Is Paying Out Less In Dividends Than Last Year

Sep 15
China Pioneer Pharma Holdings (HKG:1345) Is Paying Out Less In Dividends Than Last Year

China Pioneer Pharma Holdings (HKG:1345) Has Announced That Its Dividend Will Be Reduced To HK$0.056

Sep 01
China Pioneer Pharma Holdings (HKG:1345) Has Announced That Its Dividend Will Be Reduced To HK$0.056

China Pioneer Pharma Holdings (HKG:1345) Will Be Looking To Turn Around Its Returns

Aug 26
China Pioneer Pharma Holdings (HKG:1345) Will Be Looking To Turn Around Its Returns

Returns On Capital At China Pioneer Pharma Holdings (HKG:1345) Paint A Concerning Picture

May 22
Returns On Capital At China Pioneer Pharma Holdings (HKG:1345) Paint A Concerning Picture

We Think China Pioneer Pharma Holdings (HKG:1345) Can Stay On Top Of Its Debt

Apr 25
We Think China Pioneer Pharma Holdings (HKG:1345) Can Stay On Top Of Its Debt

Can Mixed Financials Have A Negative Impact on China Pioneer Pharma Holdings Limited's 's (HKG:1345) Current Price Momentum?

Mar 14
Can Mixed Financials Have A Negative Impact on China Pioneer Pharma Holdings Limited's 's (HKG:1345) Current Price Momentum?

How Has China Pioneer Pharma Holdings (HKG:1345) Allocated Its Capital?

Feb 21
How Has China Pioneer Pharma Holdings (HKG:1345) Allocated Its Capital?

Should You Use China Pioneer Pharma Holdings' (HKG:1345) Statutory Earnings To Analyse It?

Feb 03
Should You Use China Pioneer Pharma Holdings' (HKG:1345) Statutory Earnings To Analyse It?

Is China Pioneer Pharma Holdings Limited (HKG:1345) At Risk Of Cutting Its Dividend?

Jan 16
Is China Pioneer Pharma Holdings Limited (HKG:1345) At Risk Of Cutting Its Dividend?

China Pioneer Pharma Holdings (HKG:1345) Has A Rock Solid Balance Sheet

Dec 29
China Pioneer Pharma Holdings (HKG:1345) Has A Rock Solid Balance Sheet

Is China Pioneer Pharma Holdings Limited's (HKG:1345) Stock Price Struggling As A Result Of Its Mixed Financials?

Dec 14
Is China Pioneer Pharma Holdings Limited's (HKG:1345) Stock Price Struggling As A Result Of Its Mixed Financials?

China Pioneer Pharma Holdings (HKG:1345) Has Gifted Shareholders With A Fantastic 124% Total Return On Their Investment

Nov 29
China Pioneer Pharma Holdings (HKG:1345) Has Gifted Shareholders With A Fantastic 124% Total Return On Their Investment

Desglose de ingresos y gastos

Cómo gana y gasta dinero Shanghai Pioneer Holding. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).


Historial de beneficios e ingresos

SEHK:1345 Ingresos, gastos y beneficios (CNY Millions)
FechaIngresosBeneficiosGastos G+AGastos de I+D
30 Jun 241,6481645212
31 Mar 241,6071555281
31 Dec 231,5671465350
30 Sep 231,6001685490
30 Jun 231,6341905640
31 Mar 231,5952135560
31 Dec 221,5562355480
30 Sep 221,4822165510
30 Jun 221,4081965550
31 Mar 221,4221695700
31 Dec 211,4351435850
30 Sep 211,4151175940
30 Jun 211,395916020
31 Mar 211,364725690
31 Dec 201,332525350
30 Sep 201,325455230
30 Jun 201,318375120
31 Mar 201,317715270
31 Dec 191,3161055410
30 Sep 191,304845310
30 Jun 191,293635210
31 Mar 191,459745020
31 Dec 181,624854830
30 Sep 181,8511714730
30 Jun 182,0772584630
31 Mar 182,1162694500
31 Dec 172,1542794370
30 Sep 172,0832794190
30 Jun 172,0122804010
31 Mar 171,9012593760
31 Dec 161,7902373510
30 Sep 161,6271742970
30 Jun 161,4641112430
31 Mar 161,4621432230
31 Dec 151,4611742020
30 Sep 151,5332312080
30 Jun 151,6052872130
31 Mar 151,5732742100
31 Dec 141,5402622080
30 Sep 141,5002621840
30 Jun 141,4602631610
31 Mar 141,3662501480
31 Dec 131,2722381350

Ingresos de calidad: 1345 tiene ganancias de alta calidad.

Margen de beneficios creciente: Los actuales márgenes de beneficio(9.9%) de 1345 son inferiores a los del año pasado (11.6%).


Análisis del flujo de caja libre vs. Beneficios


Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: En los últimos 5 años, los beneficios de l1345 han crecido significativamente en un 23.4% al año.

Acelerando crecimiento: 1345 ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.

Beneficios vs. Industria: 1345 tuvo un crecimiento negativo de los beneficios (-13.9%) durante el año pasado, lo que dificulta la comparación con la media de la industria Healthcare (-16.9%).


Rentabilidad financiera

Alta ROE: La rentabilidad financiera de 1345 (12.8%) se considera baja.


Rentabilidad económica


Rendimiento del capital invertido


Descubre empresas con buenos resultados en el pasado